Home / About
Welcome to Rhenium, your premier destination for cutting-edge laboratory, research, diagnostic, and personalized medicine solutions in Israel. As a trusted partner, we collaborate with industry leaders like Thermo Fisher Scientific, Beckman Coulter, Leica, Pall, Olympus, Abbott, and many others to bring innovative and professional solutions to our vast customer network, which spans over 15,000 clients.
At Rhenium, our mission is clear: we are dedicated to empowering our customers to achieve groundbreaking discoveries and advancements in healthcare. We achieve this by leading with innovation, providing expert knowledge-based solutions, and delivering best-in-class services to both our valued customers and esteemed suppliers.
With a commitment to excellence and a passion for pushing the boundaries of possibility, Rhenium is your partner of choice in driving progress and revolutionizing the future of healthcare. Join us on our journey towards innovation, discovery, and excellence.
The company is co-owned by the founder Dror Israeli and Fortissimo Capital
Dror Israeli, the visionary founder and chairman of Rhenium since 1991, has significantly transformed healthcare solutions in Israel. His dedication to excellence and innovation has positioned Rhenium as a premier supplier of state-of-the-art technologies and comprehensive solutions. Under his leadership, Rhenium has flourished, forming valuable partnerships with researchers, medical professionals, and industry authorities. Dror’s commitment to a culture of innovation encourages creativity, professional development, and team collaboration, driving the company to surpass expectations.
Fortissimo Capital, a prominent private equity fund in Israel, is known for its innovative approach to investments in technology and industrial companies. As co-owner of Rhenium, Fortissimo Capital’s expertise in business development and strategic planning aids Rhenium’s expansion and success. Their investment underscores a commitment to advancing healthcare solutions and aligns with Rhenium’s vision of revolutionizing healthcare through emerging technologies and personalized medicine.
Group CEO
VP Rhenium Bio Science
VP Rhenium Medical
CEO Oncotest, VP Rhenium
Precision Medicine
CEO Eisenberg
CMO
CFO
CTiO
HR Director